Outcome of Board Meeting

Q1FY27 results (audited): Standalone: Revenue 27.0bn +13.6% y-y (23.4bn) PAT 4.6bn +50.9% y-y (3.0bn) Consolidated: Revenue 43.8bn +17.5% y-y (37.3bn) EBITDA 11.8bn +9.5% y-y (10.8bn) EBITDA margin 26.9% (28.9%) -200 bps y-y PAT 4.9bn +10.8% y-y (4.4bn) FY26 results: Standalone: Revenue 94.7bn +6.2% y-y (89.1bn) EBITDA 31.1bn +7.7% y-y (28.9bn) EBITDA margin 32.9% (32.4%) +50 bps y-y PAT 14.0bn +7.1% y-y (13.1bn) Consolidated: Revenue 158.8bn +10.5% y-y (143.8bn) EBITDA 45.0bn +11.4% y-y (40.4bn) EBITDA margin 28.4% (28.1%) +30 bps y-y PAT 18.6bn +11.1% y-y (16.7bn) Dividend: 62 per equity share for FY26 (approved 23 July 2026) Commentary: Mphasis reported strong Q1 FY27 revenue growth with new contract wins of USD 461 million, 63% AI-led, and expects further acceleration in Q2 FY27.